Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04260308
Other study ID # IRBID:TJ-C 20200107
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date February 3, 2020
Est. completion date April 20, 2020

Study information

Verified date February 2020
Source Huazhong University of Science and Technology
Contact Yuhong Dai
Phone +86 13476229575
Email eier_dai@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Due to the outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, Hubei province, medical staff and residents are facing great psychological pressure, the investigator plan to use electronic questionnaire to carry out investigation research.


Description:

From December 2019, 12 cases of new coronavirus pneumonia broke out in Wuhan, and then the epidemic spread rapidly. Till February 1, 2020, there were 14446 confirmed cases in China, 19544 suspected cases, and 304 deaths. There were confirmed cases reported in 34 provincial administrative regions in China; 23 foreign countries reported new coronavirus pneumonia cases, 147 confirmed cases. In the face of the rapid spread of the epidemic, people's panic and anxiety have seriously affected the prevention and control of the epidemic. In the face of the occupational exposure risk and treatment brought by the sudden outbreak of the epidemic, the change of mental state of medical staff may affect the prevention and control of the epidemic. In order to help the epidemic prevention and control, the investigator plan to carry out investigation research.


Recruitment information / eligibility

Status Recruiting
Enrollment 30000
Est. completion date April 20, 2020
Est. primary completion date April 15, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- can use mobil phone or computer

- volunteer to take part in the investigation

Exclusion Criteria:

- can not use phone or computer

- unwilling to take part in the investigation

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Tongji Hospital,Tongji Medical College Affiliated,Huazhong University of Science & Technology Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Huazhong University of Science and Technology

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary GHQ-12(general health questionnaire-12) GHQ-12(general health questionnaire-12): minimal score 0, maximal score 12, higher scores mean a better or worse outcome. 2 weeks
Secondary IES-R(Impact of Event Scale-Revised) IES-R(Impact of Event Scale-Revised):score range:0-88, the higher the worse 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT04360837 - PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients N/A
Recruiting NCT04331613 - Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS Phase 1/Phase 2